Skip to main content
OpenTrials

Clinical trial condition

Non-small Cell Lung Cancer

Explore clinical trials studying Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

1,335 public trials 329 recruiting studies
Refine in advanced search Browse all conditions

Non-small Cell Lung Cancer trial results

Active, Not Recruiting

A Study to Evaluate Chemotherapy Plus Osimertinib Against Chemotherapy Plus Placebo in Patients With Non-small Cell Lung Cancer (NSCLC)

NCT04765059

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Silver Spring, Maryland, United States
  • Research Site Boston, Massachusetts, United States
  • Research Site Beijing, China
  • Research Site Beijing, China
View all 40 locations
View Trial Details
Active, Not Recruiting

A Global Study to Assess the Effects of Osimertinib in Participants With EGFRm Stage IA2-IA3 NSCLC Following Complete Tumour Resection

NCT05120349

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site Anchorage, Alaska, United States
  • Research Site Los Angeles, California, United States
  • Research Site Orange, California, United States
  • Research Site Grand Junction, Colorado, United States
View all 139 locations
View Trial Details
Active, Not Recruiting

A Study of Atezolizumab in High PD-L1 Expression, Chemotherapy-Naïve Patients With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer

NCT05047250

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Beijing Tiantan Hospital,Capital Medical University Beijing, China
  • Xuanwu Hospital, Capital Medical University Beijing, China
  • Beijing Chest Hospital Beijing, China
  • The Third Xiangya Hospital Of Central South University Changsha, China
View all 18 locations
View Trial Details
Active, Not Recruiting

A Study to See How Well and How Safely Different Treatments Work in a Group of Participants With Non-Small Cell Lung Cancer (NSCLC)

NCT06624059

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Royal North Shore Hospital St Leonards, New South Wales, Australia
  • Sir Charles Gairdner Hospital Nedlands, Western Australia, Australia
  • Instituto do Cancer do Estado de Sao Paulo - ICESP São Paulo, Brazil
  • RedSalud Vitacura Santiago, Chile
View Trial Details
Active, Not Recruiting

Study to Assess Neoadjuvant Durvalumab (D) and Platinum-Based Chemotherapy (CT), Followed by Either Surgery and Adjuvant D or CRT and Consolidation D, in Resectable or Borderline Resectable Stage IIB-IIIB NSCLC (MDT-BRIDGE)

NCT05925530

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site The Bronx, New York, United States
  • Research Site Houston, Texas, United States
  • Research Site Charlottesville, Virginia, United States
  • Research Site Vienna, Austria
View all 49 locations
View Trial Details
Active, Not Recruiting

Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung Cancer

NCT05132075

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Valley Medical Center Research Renton, Washington, United States
  • Novartis Investigative Site CABA, Buenos Aires, Argentina
  • Novartis Investigative Site Pilar, Buenos Aires, Argentina
  • Novartis Investigative Site Auchenflower, Queensland, Australia
View all 51 locations
View Trial Details
Active, Not Recruiting

A Global Study to Assess the Effects of Durvalumab With Oleclumab or Durvalumab With Monalizumab Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer

NCT05221840

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Research Site San Diego, California, United States
  • Research Site New Haven, Connecticut, United States
  • Research Site Stuart, Florida, United States
  • Research Site Urbana, Illinois, United States
View all 202 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating the Efficacy and Safety of Divarasib Versus Sotorasib or Adagrasib in Participants With Previously Treated KRAS G12C-positive Advanced or Metastatic Non-Small Cell Lung Cancer

NCT06497556

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Banner Health MD Anderson AZ Gilbert, Arizona, United States
  • Los Angeles Cancer Network Los Angeles, California, United States
  • UCLA Hematology / Oncology Clinic Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 151 locations
View Trial Details
Active, Not Recruiting

Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors

NCT04140500

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +32 more
Locations
  • Rigshospitalet København Ø, Denmark
  • Odense Universitetshospital, Onkologisk Afdeling R Odense C, Denmark
  • LLC Arensia Explorer Medicine Tbilisi, Georgia
  • Hadassah University Hospital - Ein Kerem Jerusaelm, Israel
View all 25 locations
View Trial Details

Related conditions